85
Participants
Start Date
March 28, 2017
Primary Completion Date
September 20, 2019
Study Completion Date
September 20, 2019
Lithium sulphate prolonged-release 660 mg
Oral administration of one tablet once or twice daily (one tablet in the morning and one tablet in the evening) or two tablets in a single dose (two tablets in the evening) of Lithium sulphate 660 mg (Lithium sulphate dose will be individualised for each patient according to the relevant SmPC). Treatment duration: 3 months.
Lithium carbonate immediate-release 150 mg and 300 mg
Oral administration of 300-1800 mg daily divided into 2-6 doses of Lithium carbonate capsules (Lithium carbonate dose will be individualised for each patient according to the relevant SmPC). Treatment duration: 3 months.
IRCCS Azienda Ospedaliera Universitaria San Martino IST - Clinica Psichiatrica, Genova
Azienda Ospedaliera Papa Giovanni XXIII - Servizio Psichiatrico di Diagnosi e Cura (SPDC 1), Bergamo
Azienda Ospedaliera Universitaria Senese - Dip. Interaziendale di salute mentale - Psichiatria, Siena
Azienda Ospedaliera Universitaria Pisana - Psichiatria 1, Pisa
Ospedale San Giovanni di Dio di Orbetello Unità Funzionale Salute Mentale, Orbetello
Azienda Ospedaliera Sant'Andrea - Dip. Di Neuroscienze, Salute mentale e Organi di senso- NESMOS, Roma
Collaborators (1)
Mediolanum Cardio Research
OTHER
Aziende Chimiche Riunite Angelini Francesco S.p.A
INDUSTRY